Analysis of data from more than 2.2 million vaginal deliveries shows that episiotomy declined between 2006 and 2012 and nonmedical factors may have been at play. The findings were published in a Research Letter in JAMA.
Analysis of data from more than 2.2 million vaginal deliveries shows that episiotomy declined between 2006 and 2012 and nonmedical factors may have been at play. The findings were published in a Research Letter in JAMA.
The deliveries were identified in an insurance claims database by researchers from Columbia University College of Physicians and Surgeons. More than 500 hospitals or 15% of hospitalizations nationally are reflected in the Perspective database. Of the 2,261,070 vaginal deliveries represented in the analysis, 325,193 included episiotomy.
Between 2006 and 2012, the authors found, rates of the procedure declined from 17.3% to 11.6% (95% CI, 17.2%-17.4% vs 95% CI, 11.5%-11.7%). Episiotomy was more common among white women than among black women (15.7%; 95% CI, 15.6%-15.8% vs 7.9%; 95% CI, 7.8%-8.0%; P<.001) and among those with commercial insurance versus Medicaid (17.2%; 95% CI, 17.1%-17.3% vs 11.2%; 95% CI, 11.1%-11.3%; P<.001).
Tech Tools: Cell free DNA and oncology
Deliveries with accepted indications for episiotomy, such as shoulder dystocia, fetal distress, and fetal heart rate abnormalities, were excluded from the analysis. The researchers used multivariable mixed-effects log-linear models and a generalized linear mixed model to calculate between-hospital variation in the procedure. Hospital rates of episiotomy were highly variable, with a mean adjusted rate of 34.1% among the 10% of institutions that performed the procedure most frequently, compared with 2.5% among the 10% that performed it least frequently.
Adoption of the American College of Obstetricians and Gynecologists’ 2006 recommendation to limit routine episiotomy, the authors said, may have triggered the decline but they also cited insurance, race, rurality, and hospital teaching status as playing a role. Among the limitations of their analysis, they noted, were the possibility that billing data did not capture all episiotomies and that the sample may not be representative of all hospitals in the United States.
To get weekly advice for today's Ob/Gyn, subscribe to the Contemporary OB/GYN Special Delivery.
Maternal sFLT1 and EDN1 linked to late-onset preeclampsia
November 25th 2024A new study highlights the association of maternal soluble Fms-like tyrosine kinase 1 and endothelin 1 with preeclampsia severity, offering insights into the pathogenesis of early- and late-onset forms of the condition.
Read More
S4E1: New RNA platform can predict pregnancy complications
February 11th 2022In this episode of Pap Talk, Contemporary OB/GYN® sat down with Maneesh Jain, CEO of Mirvie, and Michal Elovitz, MD, chief medical advisor at Mirvie, a new RNA platform that is able to predict pregnancy complications by revealing the biology of each pregnancy. They discussed recently published data regarding the platform's ability to predict preeclampsia and preterm birth.
Listen
Early preterm birth risk linked to low PlGF levels during pregnancy screening
November 20th 2024New research highlights that low levels of placental growth factor during mid-pregnancy screening can effectively predict early preterm birth, offering a potential tool to enhance maternal and infant health outcomes.
Read More